Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.08 AUD
Change Today 0.00 / 0.00%
Volume 0.0
As of 1:36 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

medigard ltd (MGZ) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/10/15 - A$0.14
52 Week Low
10/20/14 - A$0.01
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDIGARD LTD (MGZ)

Related News

No related news articles were found.

medigard ltd (MGZ) Related Businessweek News

No Related Businessweek News Found

medigard ltd (MGZ) Details

Medigard Limited develops medical instruments in Australia. It designs and manufactures auto-retractable syringes, manual retractable syringes, blood collection devices, and flash back needles. The company also provides intravenous valves. Medigard Limited was founded in 1999 and is based in Main Beach, Australia.

Founded in 1999

medigard ltd (MGZ) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medigard ltd (MGZ) Key Developments

Medigard Limited, Annual General Meeting, Nov 27, 2014

Medigard Limited, Annual General Meeting, Nov 27, 2014.

Medigard Limited Auditor Raises 'Going Concern' Doubt

Medigard Limited filed its Annual on Sep 29, 2014 for the period ending Jun 30, 2014. In this report its auditor, BDO International, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Medigard Limited Reports Earnings Results for the Half Year Ended December 31, 2013

Medigard Limited reported earnings results for the half year ended December 31, 2013. For the period, revenue was AUD 795 against AUD 4,506 a year ago. Loss before tax was AUD 127,921 against AUD 152,496 a year ago. Net loss for the half year after income tax expense was AUD 127,921 against AUD 152,496 a year ago. Basic earnings per share were 0.14 cents against 0.17 cents a year ago. Net cash out flow from operating activities was AUD 129,411 against AUD 111,199 a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MGZ:AU A$0.08 AUD 0.00

MGZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MGZ.
View Industry Companies

Industry Analysis


Industry Average

Valuation MGZ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6,787.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 6,372.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIGARD LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at